Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilenia Segatto

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Pathology|October 25, 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitorsIlenia Segatto, Maria Chiara Mattevi, Gian Luca Rampioni Vinciguerra, et al.
EMBO Molecular Medicine|June 1, 2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCCFrancesca Citron, Ilenia Segatto, Lorena Musco, et al.
EMBO Molecular Medicine|April 24, 2024
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancerAlice Gambelli, Anna Nespolo, Gian Luca Rampioni Vinciguerra, et al.
EMBO Molecular Medicine|July 12, 2024
Author Correction: Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancerAlice Gambelli, Anna Nespolo, Gian Luca Rampioni Vinciguerra, et al.
Iscience|May 25, 2026
Distinct 2-phenylimidazo[1,2-<i>a</i>]pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligandsKatrin Koellisch, Christine Blattner, Stefano Motta, et al.
The Journal of Pathology|November 3, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancerDavide Viotto, Francesca Russo, Ilaria Anania, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Pathology|October 25, 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitorsIlenia Segatto, Maria Chiara Mattevi, Gian Luca Rampioni Vinciguerra, et al.
EMBO Molecular Medicine|June 1, 2021
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCCFrancesca Citron, Ilenia Segatto, Lorena Musco, et al.
EMBO Molecular Medicine|April 24, 2024
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancerAlice Gambelli, Anna Nespolo, Gian Luca Rampioni Vinciguerra, et al.
EMBO Molecular Medicine|July 12, 2024
Author Correction: Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancerAlice Gambelli, Anna Nespolo, Gian Luca Rampioni Vinciguerra, et al.
Iscience|May 25, 2026
Distinct 2-phenylimidazo[1,2-<i>a</i>]pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligandsKatrin Koellisch, Christine Blattner, Stefano Motta, et al.
The Journal of Pathology|November 3, 2020
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancerDavide Viotto, Francesca Russo, Ilaria Anania, et al.
Pageof 4